Alopecia Areata in NYC: Causes, Triggers, and Regenerative Treatment Options

Understanding Alopecia Areata

Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, causing sudden, patchy hair loss. Unlike androgenetic alopecia (hereditary pattern baldness), alopecia areata does not follow a predictable pattern and can affect any hair-bearing area — scalp, eyebrows, eyelashes, and body hair. In more severe forms, it can progress to total scalp hair loss (alopecia totalis) or complete body hair loss (alopecia universalis).

It affects approximately 2% of the population and can occur at any age, though onset in the teens and twenties is common. While many patients experience spontaneous regrowth in mild cases, others face chronic or recurrent episodes that significantly impact quality of life.

At Regen Health Physicians NYC, we approach alopecia areata through a regenerative and integrative lens — addressing both the autoimmune root cause and the follicular environment simultaneously.

What Triggers Alopecia Areata?

The Autoimmune Mechanism

In alopecia areata, T lymphocytes infiltrate the hair follicle, disrupting its normal immune privilege (the ability to evade immune surveillance). The trigger for this immune breakdown is multifactorial:

• Genetic predisposition — First-degree relatives with alopecia areata or other autoimmune conditions (thyroid disease, vitiligo, rheumatoid arthritis) indicate elevated risk
• Acute psychological stress — Emotional trauma or chronic stress dysregulates immune signaling and is frequently reported as a precipitating event
• Physical stress and illness — Major infection, surgery, or metabolic disruption can precede an episode
• Hormonal changes — Postpartum hormonal shifts are a known trigger in women
• Gut dysbiosis — Emerging research links intestinal permeability and gut microbiome imbalance to autoimmune activity, including alopecia areata

What's Happening at the Follicle Level

The hair follicle enters a prolonged telogen (resting) phase under immune attack. The follicle itself is not destroyed in early alopecia areata — it remains viable below the scalp surface — which is why spontaneous regrowth and treatment-induced regrowth are possible even after extended periods of loss.

Conventional Treatments and Their Limitations

Standard dermatological treatments for alopecia areata include:

• Intralesional or topical corticosteroids: Reduce local inflammation; effective for limited patches but carry risks of skin atrophy with repeated use
• Minoxidil: Extends anagen phase; modest benefit as a standalone treatment
• JAK inhibitors (ritlecitinib, baricitinib): Newer FDA-approved oral medications showing strong efficacy for severe alopecia areata, but carry risks including immunosuppression, and are expensive
• DNCB/DPCP contact immunotherapy: Irritates the scalp to redirect the immune response; unpredictable results

These approaches address symptoms but may not resolve the underlying immune dysregulation or improve follicular health.

Regenerative Approaches at RHPNY

PRP (Platelet-Rich Plasma) for Alopecia Areata

PRP therapy involves concentrating growth factors from your own blood and injecting them into affected areas of the scalp. For alopecia areata, the mechanism includes:

• Delivery of anti-inflammatory cytokines that may help re-establish follicular immune privilege
• Stimulation of dermal papilla cells (the stem cells that drive follicular cycling)
• Improved scalp microcirculation and nutrient delivery

Multiple clinical studies have examined PRP for alopecia areata, with results ranging from partial to complete regrowth in patches treated over multiple sessions. A 2021 systematic review in Journal of Cosmetic Dermatology found PRP superior to placebo injections for regrowth and hair density in alopecia areata patients.

At RHPNY, PRP scalp injections are typically performed in a series of 3–4 sessions spaced 4–6 weeks apart, followed by maintenance treatments every 3–6 months.

Addressing the Immune Root Cause

Because alopecia areata is driven by immune dysfunction, we also evaluate and address systemic immune health through:

• Gut health assessment: Correcting intestinal permeability and dysbiosis using targeted protocols
• Anti-inflammatory nutrition: Reducing dietary triggers that amplify autoimmune activity
• Stress and cortisol management: HPA axis evaluation and cortisol rhythm testing
• Thyroid and hormonal optimization: Coexisting thyroid disease or hormonal imbalance is common in alopecia areata patients

If chronic disease factors are contributing, Dr. Dhaliwal integrates those into a unified treatment plan.

Peptide Support

Certain peptides may offer adjunct benefit. Thymosin Alpha-1 — a peptide that modulates T-cell activity — has been explored for its immune-regulatory properties in autoimmune conditions. This is discussed on a patient-by-patient basis at RHPNY.

What to Expect

A first consultation at Regen Health Physicians includes a detailed hair and scalp evaluation, trichoscopy imaging when appropriate, labs to assess hormonal and inflammatory status, and a customized treatment plan. Many patients with limited alopecia areata patches see meaningful regrowth within 3–6 months of a regenerative protocol.

If you're experiencing patchy hair loss or have been diagnosed with alopecia areata, book a consultation with Dr. Ajit Dhaliwal to explore your options.

---

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. PRP therapy for alopecia areata is not FDA-approved for this indication. Individual results vary. Consult a qualified physician before beginning any treatment.